CLASS II ONGOING Device recall · Reported 3 Apr 2024 · FDA Enforcement Report

Aptima CMV Quant Assay, Reference numbers: AW recalled by Hologic

Hologic is recalling Aptima CMV Quant Assay, Reference numbers: AW-22600-001, AW-25509-001, and AW-26381-001, distributed nationwide in the US. The recall was initiated on 14 Sep 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 402941/ UDI:15420045514553
Quantity recalled684 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1371-2024
FDA event ID
94038
Recalling firm
Hologic, San Diego, CA
Classification
Class II
Status
Ongoing
Recall initiated
14 Sep 2023
FDA classified
22 Mar 2024
Reported
3 Apr 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

14 Sep 2023Recall initiated by company
22 Mar 2024Classified by FDA+190 days
3 Apr 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Use of assay along with plasma specimen may result in error code which would invalidate sample.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Aptima CMV Quant Assay, Reference numbers: AW-22600-001, AW-25509-001, and AW-26381-001 Amplification Reagent, Enzyme Reagent, Promoter Reagent, Amplification Reconstitution Solution, Enzyme Reconstitution Solution, Promoter Reconstruction solution, Target capture Reagent, Reconstitution Collars.

Where it was distributed

Worldwide - US Nationwide distribution in the states of CA, CT, FL, ID, IL, MD, MI, MO, TN, TX, WI and the countries of Australia, Germany, Denmark, Spain, France, Great Britain, Italy, Norway, Qatar, Sweden.

Nationwide CaliforniaConnecticutFloridaIdahoIllinoisMarylandMichiganMissouriTennesseeTexasWisconsin

Stores named: Target

Questions about this recall

Why was it recalled?

Use of assay along with plasma specimen may result in error code which would invalidate sample.

Which lots are affected?

Lot #: 402941/ UDI:15420045514553

Where was it sold?

Worldwide - US Nationwide distribution in the states of CA, CT, FL, ID, IL, MD, MI, MO, TN, TX, WI and the countries of Australia, Germany, Denmark, Spain, France, Great Britain, Italy, Norway, Qatar, Sweden.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Hologic

All 48

Other Test Kits & Diagnostics recalls

All 2,661